FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/04/051677 [Registered on: 17/04/2023] Trial Registered Prospectively
Last Modified On: 22/03/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic 
Study Design  Other 
Public Title of Study   Effect Of Shigru-Haridradi Aschyotana (Eye Drop) with Haridrakhanda and Bilvadi Aschyotana with Haridrakhanda in Vataja Abhishyanda(Simple Allergic Conjunctivitis). 
Scientific Title of Study   Efficacy Of Shigru-Haridradi Aschyotana (Eye Drop) with Haridrakhanda and Bilvadi Aschyotana with Haridrakhanda in the Management of Vataja Abhishyanda (Simple Allergic Conjunctivitis) - An Open Labelled Randomized Comparative Clinical Trial. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pratiksha Virwal 
Designation  MS Scholar 
Affiliation  Institute of Teaching and Research in Ayurveda 
Address  4th floor Department of Shalakyatantra Institute of Teaching and Research in Ayurveda Opposite Reliance Mart near B division city police station Jamnagar, Gujarat GUJARAT
Opd no.3, Shalakyatantra department, Institute of Teaching and Research in Ayurveda Opposite Reliance Mart near B division city police station Jamnagar, Gujarat
Jamnagar
GUJARAT
361008
India 
Phone  7023230244  
Fax    
Email  Pratikshavirwal7504@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Deepak Pawar 
Designation  Assistant Professor 
Affiliation  Institute of Teaching and Research in Ayurveda 
Address  4th floor Department of Shalakyatantra Institute of Teaching and Research in Ayurveda Opposite Reliance Mart near B division city police station Jamnagar, Gujarat
Opd no.3 Shalakyatantra department,Institute of Teaching and Research in Ayurveda Opposite Reliance Mart near B division city police station Jamnagar, Gujarat
Jamnagar
GUJARAT
361008
India 
Phone  7737379173  
Fax    
Email  drpawar29@itra.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Deepak Pawar 
Designation  Assistant Professor 
Affiliation  Institute of Teaching and Research in Ayurveda 
Address  4th floor Department of Shalakyatantra Institute of Teaching and Research in Ayurveda Opposite Reliance Mart near B division city police station Jamnagar, Gujarat
Opd no.3, Department of Shalakatantra Institute of Teaching and Research in Ayurveda Opposite Reliance Mart near B division city police station Jamnagar, Gujarat
Jamnagar
GUJARAT
361008
India 
Phone  7737379173  
Fax    
Email  drpawar29@itra.edu.in  
 
Source of Monetary or Material Support  
Institute of Teaching and Research in Ayurveda Opposite Reliance Mart near B division city police station Jamnagar, Gujarat,361008 
 
Primary Sponsor  
Name  Institute of Teaching and Research in Ayurveda  
Address  4th floor Department of Shalakyatantra Institute of Teaching and Research in Ayurveda Opposite Relince Mart near B division city police station Jamnagar Jamnagar 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Pratiksha Virwal  Opd no.3, Department of Shalakyatantra, ITRA Hospital Jamnagar Gujarat  4th Floor department of Shalakatantra, Institute of Teaching and Research in Ayurveda Opposite Reliance Mart near B division city police station Jamnagar, Gujarat,361008
Jamnagar
GUJARAT 
7023230244

pratikshavirwal7504@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H109||Unspecified conjunctivitis. Ayurveda Condition: SARVAGATAKSHIROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-AScyotanam, आश्च्योतनम् (Procedure Reference: Kaviraj Atrideva Gupta, Astanga Samgraha of Acharya Vagbhatta, Sutra sthan 32/4, reprinted edition (2016), Chaukhamba Krishnadas Academy Publisher, pg. 226, Procedure details: • The patient should ask to lie down in supine / semi supine position. • Patient’s eyes should be clean using wet cotton. • The eye is opened by one hand and instillation of 2 drops Luke warm Bilvadi Aschyotana with another hand will be done with the measuring dropper from 3-4cm height to Kaninika Sandhi (Inner canthus area) in each eye. • Then ask patient to rotate his/her eyes and after 1 minute install another 2 drops. In this manner total dose of 0.5ml per day for one eye should)
(1) Medicine Name: Shigru-Haridradi Aschyotana (Eye drop), Reference: Anubhuta, Route: Ocular, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 2(drops), Frequency: tds, Duration: 2 Weeks
2Intervention ArmDrugClassical(1) Medicine Name: Haridrakhanda, Reference: Shri Govind Das, Bhaishajya Ratnavali, 55/13-17, Route: Oral, Dosage Form: Khanda /Granules, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Weeks, anupAna/sahapAna: Yes(details: -lukewarm Milk), Additional Information: -
3Comparator ArmProcedure-AScyotanam, आश्च्योतनम् (Procedure Reference: Kaviraj Atrideva Gupta, Astanga Samgraha of Acharya Vagbhatta, Sutra sthan 32/4, reprinted edition (2016), Chaukhamba Krishnadas Academy Publisher, pg. 226, Procedure details: • The patient should ask to lie down in supine / semi supine position. • Patient’s eyes should be clean using wet cotton. • The eye is opened by one hand and instillation of 2 drops Luke warm Bilvadi Aschyotana with another hand will be done with the measuring dropper from 3-4cm height to Kaninika Sandhi (Inner canthus area) in each eye. • Then ask patient to rotate his/her eyes and after 1 minute install another 2 drops. In this manner total dose of 0.5ml per day for one eye should)
(1) Medicine Name: Bilvadi Aschyotana, Reference: Chakradatta, Netraroga Chikitsa Prakarana, 59/13, Route: Ocular, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 4(drops), Frequency: tds, Duration: 2 Weeks
4Comparator ArmDrugClassical(1) Medicine Name: Haridrakhanda, Reference: Shri Govind Das, Bhaishajya Ratnavali, 55/13-17, Route: Oral, Dosage Form: Khanda /Granules, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Weeks, anupAna/sahapAna: Yes(details: -lukewarm milk), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1. Patients between 18 to 50 years of age.
2. Patients having minimum three symptoms of Simple Allergic Conjunctivitis.
 
 
ExclusionCriteria 
Details  1. Patients below 18 years and above 50 years of age.
2. Patients having complications of corneal involvement like Marginal Corneal Ulcer, Dacryocystitis, Trachoma, Keratoconjunctivitis sicca, Vernal Keratoconjunctivitis, Giant papillary conjunctivitis, Atopic Keratoconjunctivitis.
3. All types of Conjunctivitis (Acute and Chronic) which are non-allergic in nature are excluded from the Study.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in Subjective and Objective Criteria of Vataja Abhishyanda (Simple Allergic Conjunctivitis).  2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Relief in Subjective and Objective Criteria of Vataja Abhishyanda (Simple Allergic Conjunctivitis).  4-6weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/05/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Introduction:Conjunctival hyperemia or Conjunctivitis (inflammation of outermost layer of the eye and innermost layer of the eyelids) is the commonest eye disorder nowadays and among them Ocular allergy represents one of the most common conditions encountered by allergists and ophthalmologists. It has an equal distribution throughout the world, without any exception to the developed and under developed countries. It is categorized as infective and non-infective conjunctivitis. Simple Allergic Conjunctivitis is a non-infective type of conjunctivitis in which inflammation of conjunctiva occurs due to allergic or hypersensitive reactions by dust, pollen, air pollution and other environmental factor which may be immediate or delayed.Significance:Prevalence rate of Simple Allergic Conjunctivitis is 10% to 30% of the general population,Recurrence in 41-62% cases have an equal distribution throughout the world, without any exception to the developed and under developed countries.In the management of Simple Allergic Conjunctivitis most of the drugs are Anti-allergic and Immune-modulators areused. But both have temporary effects and high recurrence rate.So, to prove the efficacy there is need of Ayurvedic interventions like Aschyotana (Eye drop) therapy (alternative medicine) and Ayurvedic Anti-allergic oral medication which is devoid of side effects and reduce the recurrence rate of Vataja Abhishyanda (Simple Allergic Conjunctivitis).Materials and Methods:Minimum 30 patients will be enrolled on the basis of symptoms of Pricking Pain (Nistoda), Foreign body sensation (Sangharsh), Redness (Ragata), Dryness- Feeling (Vishushka Bhava), Clean /Watery discharge (Achchasruta), Mild Chemosis (Alpa Shopha) , Itching (Kandu), Burning sensation(Daha).Group A Patients will receive  Shigru-Haridradi Aschyotana (Eye drop) along with Haridrakhanda and Group B Patients will receive Bilvadi Aschyotana along with Haridrakhanda .Results and Discussion:Data generated during the above study will be presented in a systematic manner and shall be analysed statistically. Follow up:After completion of therapy, follow up will be done for 2 weeks to assess the status of patient, where patient will be asked to report fortnightly.Adverse effects: this proposal will be reviewed and approved by I.T.R.A. Institutional Ethical Committee , Which is having the responsibility to protect the research participants from harm. These drugs have no known unwanted effects . it is possible that it may also cause some problems that we are not aware of. Adverse Drug Reaction if any observed will be reported to the Pharmacovigilance cell of I.T.R.A. 
Close